Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

mike_crooks_web

Astellas Pharma Europe appoints Mike Crooks to head up its UK operations

January 19, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas Pharma, Mike Crooks

Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas Pharma, has appointed Mike Crooks as its new UK general manager. …
Appointment
Bayer image

Bayer’s colorectal cancer drug increases survival

January 19, 2012 Research and Development, Sales and Marketing Bayer, colectoral cancer, regorafenib

Bayer and Onyx’s colorectal cancer drug regorafenib increased overall survival for late-stage patients, according to new data. The Phase III …
News

Former Bristol-Myers Squibb man becomes head of Savient Europe

January 18, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Savient

Savient Pharmaceuticals has appointed David Veitch as the new president of its European division. Veitch joins the specialist biopharma firm …
Appointment
Pfizer image

Pfizer pulls plug on Alzheimer’s drug

January 18, 2012 Research and Development, Sales and Marketing Medivation, Pfizer, dimebon

Pfizer and Medivation have written off their Alzheimer’s candidate dimebon after another Phase III failure.  The firms said a 12-month …
News
Novartis image

Novartis reverses plant closure decision

January 18, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Basel, Diovan, Novartis, Nyon, closure, job cuts

Novartis has said it will not close down a plant in Switzerland that had been due for closure, and has …
News
Tamiflu image

BMJ blasts Roche for withholding Tamiflu data

January 18, 2012 Research and Development, Sales and Marketing BMJ, EMA, Roche, Tamiflu, WHO

Roche is still withholding Tamiflu data from researchers, claims the British Medical Journal. Two years after Roche said it would …
News

The work of NICE International

January 17, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kalipso Chalkidou, NICE

NICE, or the National Institute for Health and Clinical Excellence, to give it its full title, is world famous for …
Feature

CoreLab Partners opens office in Tokyo, Japan

January 17, 2012 Research and Development

Princeton, NJ January 17, 2012 – Signaling a further commitment to expand its business model in the Pacific Rim and …
News
Press release

Oxford BioTherapeutics appoints C. Glenn Begley as a senior clinical advisor

January 17, 2012 Business Services, Research and Development, Sales and Marketing C. Glenn Begley, Oxford Biotherapeutics

Oxford BioTherapeutics has appointed C. Glenn Begley as a senior clinical advisor and non-executive director of the firm.  Dr Begley, …
Appointment

Contract research news in brief

January 17, 2012 Manufacturing and Production, Research and Development AAIPharma and General Dynamics, Charles River Labs, Covance, ICON, ShangPharma

A round-up of developments in the contract research sector, including updates on Charles River Labs, ShangPharma, Icon, Covance, AAIPharma and …
News

Otsuka and UCB scale down collaboration

January 16, 2012 Research and Development, Sales and Marketing Lundbeck, Otsuka, UCB

Otsuka and UCB have scaled back the scope of their collaboration, and will now focus on developing drugs for the …
News

AstraZeneca looks for new partners to bolster pipeline

January 16, 2012 Business Services, Research and Development, Sales and Marketing AstraZeneca, BMS

AstraZeneca has used a recent healthcare conference in San Francisco to call for new drug development partners. Speaking at the …
News

Novartis to cut 2,000 US jobs

January 13, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Diovan, Novartis, job cuts

Novartis will slash 1,960 jobs in the US as it prepares for life without its blockbuster medicine Diovan. The hypertension …
News

Pharma unprepared for annus horribilis

January 12, 2012 Research and Development, Sales and Marketing AZ, Pfizer, Takeda, patents, pharma

A new survey shows pharma is not prepared to deal with the tough year ahead as many blockbuster drugs begin …
News

Merck facility reborn as science park

January 11, 2012 Research and Development BioCity, MSD, Merck, Newhouse, Pfizer, Roslin BioCentre, Scotland

A former Merck research site in Scotland has been given a new lease of life as a biotech science park. …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026